We are live on ! Find out more
OC

Oakworth Capital Portfolio holdings

AUM $2.1B
1-Year Est. Return 24.07%
This Fund
S&P 500
This Quarter Est. Return
+1.79%
1 Year Est. Return
+24.07%
3 Year Est. Return
+64.28%
5 Year Est. Return
+64.42%
10 Year Est. Return
+240.11%
AUM
$482M
AUM Growth
+$63.3M
Cap. Flow
+$15.4M
Cap. Flow %
3.2%
Top 10 Hldgs %
61.98%
Holding
657
New
37
Increased
120
Reduced
45
Closed
13

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$508K
2
ADEA icon
Adeia
ADEA
+$327K
3
MON
Monsanto Co
MON
+$308K
4
SWKS icon
Skyworks Solutions
SWKS
+$275K
5
EGN
Energen
EGN
+$192K

Sector Composition

Rank Sector Weight
1 Financials 6.42%
2 Technology 6.21%
3 Healthcare 4.78%
4 Communication Services 3.72%
5 Industrials 2.1%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MON
651
DELISTED
Monsanto Co
MON
-2,459
Closed -$308K
FIGY
652
DELISTED
Barclays ETN+ FI Enhanced Global High Yield ETN
FIGY
-289
Closed -$47K
CBI
653
DELISTED
Chicago Bridge & Iron Nv
CBI
-450
Closed -$7K
FTR
654
DELISTED
Frontier Communications Corp.
FTR
$0 ﹤0.01%
9
FEEU
655
DELISTED
Barclays ETN+ FI Enhanced Europe 50 ETN
FEEU
-218
Closed -$28K

Similar funds

Oakworth Capital's Q2 2018 Portfolio in Review

As of Q2 2018, Oakworth Capital held 657 positions worth $482M, up 15% from $419M the previous quarter. Its ten largest holdings account for 62% of the portfolio.

Oakworth Capital deployed $15.4M of net new capital in Q2 2018, opening 37 new positions and adding to 120 existing holdings. Its largest new stake was Texas Pacific Land: 8,640 shares worth $668K.

By sector, the portfolio is most concentrated in Financials at 6.4% of assets, down from 7.3% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was Pfizer, an estimated $508K trimmed.

  • Oakworth Capital's largest Q2 2018 buy was Texas Pacific Land: 8,640 shares worth $668K.
  • Oakworth Capital added most to iShares Core MSCI EAFE ETF in Q2 2018, an estimated $2.37M increase.
  • Oakworth Capital's biggest Q2 2018 reduction was Pfizer, cutting an estimated $508K.
  • Oakworth Capital fully exited Adeia in Q2 2018, selling an estimated $327K.
  • Oakworth Capital's ten largest holdings make up 62% of its $482M portfolio in Q2 2018.
  • Oakworth Capital opened 37 new positions and closed 13 in Q2 2018.
  • Oakworth Capital's portfolio value rose 15% quarter-over-quarter to $482M.

Based on Oakworth Capital's 13F filing for Q2 2018, filed 7 Aug 2018.